NYSE:COV (COV) (COV) Stock Price, News & Analysis → Heard about the 72-Hour Profit Surge? Read this… (From DTI) (Ad) Free COV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume3.88 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here About (COV) Stock (NYSE:COV)Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company’s brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company’s segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company’s products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.Read More Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here COV Stock News HeadlinesMay 29 at 6:05 PM | msn.comDoctors Warn About 2 New COVID Variants—What to Know About ‘FLiRT’ StrainsMay 28 at 9:39 AM | msn.comStudy shows enforced masking on long flights prevents SARS-CoV-2 transmissionMay 27, 2024 | msn.comRising COVID Cases: Essential Information on New FLiRT VariantsMay 26, 2024 | msn.comMaternal Covid infection may raise social and breathing troubles in babiesMay 26, 2024 | markets.businessinsider.comCost Plus Med Tech Launches Revolutionary At-Home Flu A/B & COVID-19 Multiplex Rapid TestMay 24, 2024 | msn.comHow COVID-19 'breakthrough' infections alter your immune cellsMay 24, 2024 | foxnews.comWhat to know about the new 'FLiRT' COVID variantsMay 23, 2024 | msn.comCork health officials on lookout for new 'FLiRT' Covid variantMay 23, 2024 | theglobeandmail.comClosing Bell: CI Hlth Care Giant Cov Call ETF down on Wednesday (FHI)May 23, 2024 | theglobeandmail.comClosing Bell: BMO US High Div Cov Call Hgd ETF up on Wednesday (ZWS)May 23, 2024 | msn.comChildren exposed to SARS-CoV-2 in womb or as newborns may face increased social and respiratory problemsMay 22, 2024 | msn.com100-year-old BCG vaccine protects individuals with type 1 diabetes from infectious diseasesMay 20, 2024 | msn.comLVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variantsMay 18, 2024 | msn.comRepeat COVID-19 vaccinations elicit antibodies that neutralize variants, other virusesMay 17, 2024 | msn.comCould a cup of tea keep Covid-19 at bay?May 17, 2024 | msn.comPandemic treaty talks in Geneva get one final big pushMay 17, 2024 | msn.comA new COVID-19 variant, FLiRT, could cause a summer surge. These are the symptoms.May 17, 2024 | msn.comPre-vaccine COVID-19: US study reveals hospitalization rate of 5.7% and fatality rate of 1.7%May 16, 2024 | theglobeandmail.comClosing Bell: CI Energy Giants Cov Call ETF flat on Friday (NXF)May 15, 2024 | msn.comCOVID-19 linked to rise in autoimmune lung disease, study findsMay 15, 2024 | msn.comNew COVID-19 'FLiRT' variants are now the dominant variant. Could there be a summer surge?May 15, 2024 | msn.comNew study identifies mechanism of immune evasion of SARS-CoV-2 and variantsMay 14, 2024 | msn.comStudy shows virus that causes COVID-19 can penetrate blood-retinal-barrier and could damage visionMay 14, 2024 | msn.comFinding the chink in coronavirus's armor—experiment reveals how the main protease of SARS-CoV-2 protects itselfMay 14, 2024 | msn.comCurcuminoid compounds show promise against COVID-19 in neuronal cellsSee More Headlines Company Calendar Last Earnings11/05/2014Today5/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNYSE:COV CUSIPG2554F11 CIK1385187 WebN/A Phone+353-1-4381700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesGary L. Ellis (Age 61)President, Chief Executive Officer Charles J. Dockendorff (Age 63)Chief Financial Officer, Executive Vice President Bryan C. Hanson (Age 50)Group President, Covidien John H. Masterson (Age 54)Senior Vice President, General Counsel Michael P. Dunford (Age 54)Senior Vice President - Human Resources James C. Clemmer (Age 53)Senior Vice President and President - Medical Supplies Business Amy A. McBride-Wendell (Age 53)Senior Vice President - Strategy and Business Development Jacqueline F. Strayer (Age 58)Senior Vice President-Corporate Communications Michael E. Tarnoff (Age 46)Senior Vice President,Chief Medical Officer Peter L. Wehrly (Age 57)Senior Vice President, Group President - Developed Markets More ExecutivesKey CompetitorsAbbott LaboratoriesNYSE:ABTIntuitive SurgicalNASDAQ:ISRGStrykerNYSE:SYKBoston ScientificNYSE:BSXMedtronicNYSE:MDTView All Competitors COV Stock Analysis - Frequently Asked Questions How were (COV)'s earnings last quarter? (COV) (NYSE:COV) issued its quarterly earnings results on Wednesday, November, 5th. The healthcare company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.13. The healthcare company earned $2.73 billion during the quarter, compared to analyst estimates of $2.69 billion. (COV)'s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $0.91 earnings per share. What other stocks do shareholders of (COV) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (COV) investors own include Pfizer (PFE), Chevron (CVX), Intel (INTC), Johnson & Johnson (JNJ), Boeing (BA), CVS Health (CVS), EMC (EMC), Gilead Sciences (GILD) and JPMorgan Chase & Co. (JPM). This page (NYSE:COV) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeThis unknown company solves the biggest issue with AIManward PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.